Duke and Seelos Therapeutics to Work on Parkinson’s Disease Gene Therapy
Seelos Therapeutics and Duke University have both signed a Sponsored Research Agreement, meaning they will work in tandem to evaluate and test SLS-004, a Parkinson's disease treatment. Their research aims…